Safety and tolerability of an aggressive tilt table test protocol in the evaluation of patients with suspected neurocardiogenic syncope

PACE - Pacing and Clinical Electrophysiology

Volumn 23, Issue 4 I, 2000, Pages 441-445

  Vlay, Stephen C ^a   Brodsky, Craig ^a   Vlay, Linda C ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

HUT; Isoproterenol; Neurocardiogenic syncope; Syncope

Indexed keywords

ISOPRENALINE; METOPROLOL;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD PRESSURE; CHILD; FEMALE; HEART RATE; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; PROVOCATION TEST; SAFETY; SYNCOPE; TILT TABLE TEST;

EID: 0034091619     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2000.tb00824.x     Document Type: Article

References (20)

1. Benditt DG, Remole S, Bailin S, et al. Tilt table testing for evaluation of neurally mediated (cardioneurogenic) syncope. Rationale and proposed protocols. PACE 1991; 14:1528-1537.
2. Fitzpatrick AP, Thedorakis G, Vardas P, et al. Methodology of head-up tilt testing in patients with unexplained syncope. J Am Coll Cardiol 1991; 17:125-130.
3. Almquist A, Goldenberg IF, Milstein S, et al. Provocation of bradycardia and hypotension by isoproterenol and upright position in patients with unexplained syncope. N Engl J Med 1989; 320: 346-351.
4. Fitzpatrick A, Theodorakis G, Varda P, et al. The incidence of malignant vasovagal syndrome in patients with recurrent syncope. Eur Heart J 1991; 12:389-394.
5. Kapoor WN, Brant N. Evaluation of syncope by upright tilt testing with isoproterenol. A nonspecific test. Ann Intern Med 1992; 116:358-363.
6. Grubb BP, Temesy-Armos P, Moore J. et al. Head-upright tilt-table testing in evaluation and management of the malignant vasovagal syndrome. Am J Cardiol 1992; 69:904-908.
7. Grubb BP, Wolfe D, Samoil D, et al. Recurrent unexplained syncope in the elderly: The use of head upright tilt table testing in evaluation and management. J Am Geriatr Soc 1992; 40:1123-1128.
8. Rubin AM, Rials SJ, Marinchek RA, et al. The head-up tilt table test and cardiovascular neurogenic syncope. Am Heart J 1993; 125: 476-482.
9. Sheldon R. Evaluation of a single-stage isoproterenol tilt-table test in patients with sycnope. J Am Coll Cardiol 1993; 22:114-118.
10. Brooks R, Ruskin JN, Powell AC, et al. Prospective evaluation of day-to-day reproducibility of upright tilt-table testing in unexplained syncope. Am J Cardiol 1993; 71:1289-1292.
11. Patel A, Maloney A, Damato AN. On the frequency and reproducibility of orthostatic blood pressure changes in health community-dwelling elderly during 60° head-up tilt. Am Heart J 1993; 126:184-188.
12. Barron SA, Rogovski Z, Hemli Y. Vagal cardiovascular reflexes in young persons with syncope. Ann Intern Med 1993; 118:943-946.
13. Natale A, Akhtar M, Jazayeri M, et al. Provocation of hypotension during head-up tilt testing in subjects with no history of syncope or presyncope. Circulation 1995; 92:54-58.
14. Raviele A, Menozzi C, Brignole M, et al. Value of head-up tilt testing potentiated with sublingual nitroglycerine to assess the origin of unexplained syncope. Am J Cardiol 1995; 76:267-272.
15. Benditt DG, Erickson M, Gammage MD, et al. A synopsis: Neurocardiogenic syncope, an international symposium, 1996. PACE 1997; 20:851-860.
16. Benditt DG, Ferguson DW, Grubb BP, et al. ACC Expert Consensus Document: Tilt table testing for assessing syncope. J Am Coll Cardiol 1996; 28:263-275.
17. Vlay SC. Syncope. In SC Vlay (ed.): A Practical Approach to Cardiac Arrhythmias. Boston, MA, Little, Brown and Co., 1996, pp. 77-83.
18. Grubb BP, Kosinski D. Tilt table testing: Concepts and limitations. PACE 1997; 20:781-787.
19. Sheldon R, Rose S, Flanagan BN, et al. Risk factors for syncope recurrence after a positive tilt-table test in patients with syncope. Circulation 1996; 93:973-981.
20. Alehan D, Lenk M, Ozme S, et al. Comparision of sensitivity and specificity of tilt protocols with and without isoproterenol in children with unexplained syncope. PACE 1997; 20:1769-1776.